Loading clinical trials...

Lung Transplantation for Pleuroparenchymal Fibroelastosis | Clinical Trials | Clareo Health

UNKNOWNNCT05044390

Lung Transplantation for Pleuroparenchymal Fibroelastosis

This retrospective observational study will evaluate the outcomes of lung transplantation for a rare cause of interstitial lung disease called pleuroparenchymal fibroelastosis. Data will be collected ...

Lead sponsor: Hospices Civils de Lyon•4 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment30

Start dateApr 2021

Last updatedSep 14, 2021

Condition

Fibroelastosis

Locations shown

Marie Lannelongue Hospital

Le Plessis-Robinson

Hopital Louis Pradel

Lyon

Bichat Claude Bernard Hospital, APHP

Paris

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 14, 2021Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions